Company Overview and News

21
10 A-Rated Financial Stocks to Consider | InvestorPlace

2018-07-13 investorplace
JPMorgan Chase & Co (NYSE: JPM) came in with some bullish numbers this morning, with revenue up 18% for the most recent quarter. Not all the big banks were as bullish, but it does show that the financial sector is finally finding a way to make money more consistently without relying on the risky derivatives market.
PZBW LOB JPM BCML NRZ HLNE VIRT IBKR SIVB ENVA CIGI

13
AGNC Investment's Q2 2018 Income Statement And Earnings Preview - Part 2 (Hedges To The Rescue Once Again)

2018-07-09 seekingalpha
Fairly similar to the prior quarter, I am projecting AGNC will report a modest-notable gain regarding the company’s derivative instruments and other securities for the second quarter of 2018.
CHMI.PRA NYMTO MTGE ORC CHMI NYMTP AI CYS.PRA AI.PRB CYS.PRB TWO AGNC AIW TWO.PRA TWO.PRB TWO.PRC NRZ AIC NLY NLY.PRA NLY.PRECL NLY.PRD NLY.PRE CYS NLY.PRC ARR NLY.PRF NLY.PRG NYMT ARR.PRB ARR.PRA

13
Weighing The Week Ahead: Inflation On The Horizon?

2018-07-08 seekingalpha
The economic calendar is a light one, and many regular participants are on vacation. The most important data include PPI, CPI, and JOLTS, the best read on a tightening labor market. I expect pundits to put these pieces together and wonder:
ROP TOL GIS NRZ RCL

9
Chimera: Good Yield Until The Economy Turns Around

2018-07-06 seekingalpha
Its strategy of investing in subordinated bonds makes it highly exposed to a downturn in the housing market.
CIM.PRA CIM NRZ AGNC CIM.PRB

7
This 11.4%-Yielding Top-Shelf Mortgage REIT Is A Strong Buy On The Drop

2018-07-02 seekingalpha
New Residential Investment Corp. is a top-notch mortgage REIT with a promising investment portfolio. I see NRZ as a "Strong Buy".
NRZ

52
AGNC Investment's Q2 2018 Income Statement And Earnings Preview - Part 1 (Including Current Recommendation)

2018-07-02 seekingalpha
This series projects AGNC’s income statement for the second quarter of 2018. These projections help readers understand how most of the fixed-rate agency mREIT sector performed.
CHMI.PRA NYMTO ORC CHMI NYMTP AI CYS.PRA AI.PRB CYS.PRB TWO AGNC AIW TWO.PRA TWO.PRB TWO.PRC NRZ AIC NLY NLY.PRA NLY.PRECL NLY.PRD NLY.PRE CYS NLY.PRC ARR NLY.PRF NLY.PRG HTS NYMT ARR.PRB ARR.PRA

41
Top 50 High Yield Real Estate Issues Show Gains To 42.6% By June 2019

2018-06-29 seekingalpha
Landmark Infrastructure flaunted top net gains, while Orchid Island Capital had highest yield. Top ten gainers, IVR, TWO,WSR, ORC, EARN, NRZ, DX, CHMI, AJX, & LMRK ranged 10.6%-42.6% 6/28/18.
CHMI.PRA NYMTO ORC CHMI NYMTP CYS.PRA CYS.PRB EARN TWO AGNC TWO.PRA TWO.PRB TWO.PRC AJXA IVR.PRA NRZ IVR.PRB IVR.PRC DX NLY NLY.PRA NLY.PRECL NLY.PRD NLY.PRE CYS NLY.PRC NLY.PRF NLY.PRG IVR DX.PRB NYMT DX.PRA AJX

5
Has New Residential Investment (NRZ) Outpaced Other Finance Stocks This Year?

2018-06-29 zacks
Investors focused on the Finance space have likely heard of New Residential Investment (NRZ - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Finance peers, we might be able to answer that question.
NRZ PII

65
AGNC: There Are Better Yield Plays Among mREITs

2018-06-28 seekingalpha
AGNC Investment Corp (AGNC) has a double-digit dividend yield, but this seems to be too risky because its sustainability is highly questionable.
NIM FNMA FMCKI FMCKJ AMBKP AGNC ACAS FMCCO FMCCP FMCCM FMCCN NRZ FMCCI NLY FMCCJ NLY.PRA FMCCG FMCKO FMCKP NLY.PRECL NLY.PRD FMCKM FMCKN NLY.PRE FMCKK NLY.PRC FMCKL NLY.PRF NLY.PRG FMCC FMCCS FMCCT

73
Top 10 Stocks Under $20

2018-06-26 investorplace
Here at Zacks, we don’t generally classify stocks as “cheap” or “expensive”, and rather than looking at the stock’s face value, we have a system that puts an emphasis on earnings estimate revisions to find stocks that will hopefully be winners for investors.
CVGI BGFV ELY AUDC CY NRZ CFCO CFCOW CFCOU GRPN ZAGG FG TERP

77
Ain't Nothing Like The REIT Thing

2018-06-26 seekingalpha
REIT headwinds persist, including rising interest rates and bond yields, as well as the pro-growth, risk-on environment.
REG GEO BPY ARI EPR.PRG O.PRF OPRF KRG UMH.PRD UMH.PRC UMH.PRB UMH.PRA AI LADR EQR AI.PRB CORR.PRA GGP UMH AIW AVB CORR REG.PRG REG.PRF ARI.PRA NRZ ARI.PRC AIC O NLY NLY.PRA NLY.PRECL NLY.PRD NLY.PRE GGP.PRA NLY.PRC NLY.PRF NLY.PRG EPR CBL

Related Articles

CYTX: Cytori Therapeutics Analysis and Research Report

9h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

Silicon Investor Message Boards

This table lists all message boards related to NRZ / New Residential Investment Corp. on message board site Silicon Investor.

SNRZ Sunrise Assited Living, Inc
CUSIP: 64828T201